Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Asthma

Free Subscription 19.10.2026 1 Allergy 2 Am J Respir Cell Mol Biol 1 Ann Allergy Asthma Immunol 1 Arerugi 1 Eur Respir J 4 Int Arch Allergy Immunol 1 J Allergy Clin Immunol 3 Respir Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. WU X, Fan J, Ding H, Li S, et al
   Not Just Th2: Eosinophil-Associated Proteomic Networks Reveal Fundamental Differences Between COPD and Asthma.
   Allergy. 2026 Oct 10. doi: 10.1111/all.70538.
   PubMed         Abstract available
   
   

   
   Am J Respir Cell Mol Biol

2. KHANNA K, Charbit AR, Tang M, Bleecker ER, et al
   Histo-blood group secretor status does not influence mucus plugging or asthma exacerbation outcomes.
   Am J Respir Cell Mol Biol. 2026 Oct 15:aanag158. doi: 10.1093.
   PubMed         Abstract available
   
   
3. PHAM AVQ, Kwayie A, Phan ATQ, Willis KA, et al
   Pulmonary ILC2 Priming as a Link Between Severe Early-Life RSV Bronchiolitis and Asthma.
   Am J Respir Cell Mol Biol. 2026 Oct 12:aanag207. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

4. RIJAVEC M, Svetina M, Skrgat S, Zidarn M, et al
   Hereditary alpha-tryptasemia is associated with response to omalizumab in severe allergic asthma.
   Ann Allergy Asthma Immunol. 2026 Oct 15:S1081-1206(26)01271.
   PubMed         Abstract available
   
   

   
   Arerugi

5. UEHARA S, Hirai K
   [EVALUATION OF STEROID SENSITIVITY IN SEVERE ASTHMA: INVOLVEMENT OF THE PI3K PATHWAY AND RESTORATION OF SENSITIVITY BY BIOLOGICS].
   Arerugi. 2026;75:367-374.
   PubMed        
   
   

   
   Eur Respir J

6. DUVALL MG, Dorazio MH, Chiha T, Reilly RB, et al
   Dysregulated NK cell phenotype in exacerbation-prone severe asthma.
   Eur Respir J. 2026 Oct 11:2600317. doi: 10.1183/13993003.00317-2026.
   PubMed         Abstract available
   
   

   
   Int Arch Allergy Immunol

7. CAI W, Cao Y, Wang L, Zhou S, et al
   Montelukast combined with ICS/LABA improves clinical outcomes in moderate-to-severe persistent asthma by modulating T lymphocyte subset-related cytokine profiles.
   Int Arch Allergy Immunol. 2026 Oct 15:1. doi: 10.1159.
   PubMed         Abstract available
   
   
8. JIANG Q, Shao Y, Zheng Q
   Efficacy and Safety of Sublingual versus Subcutaneous Immunotherapy for Patients with Allergic Rhinitis with Asthma: A Systematic Review and Meta-analysis.
   Int Arch Allergy Immunol. 2026 Oct 13:1. doi: 10.1159.
   PubMed         Abstract available
   
   
9. LI J, Mirodilova F, Lei L
   Luteolin alleviates neurogenic inflammation in OVA-induced combined allergic rhinitis and asthma syndrome mice through TRPV1/ERK-related signaling.
   Int Arch Allergy Immunol. 2026 Oct 12:1. doi: 10.1159.
   PubMed         Abstract available
   
   
10. BUTUN TURK S, Kazancioglu A, Turktas I
    Age-Related Differences in Asthma Recognition, Follow-up, and Home-Based Exacerbation Management Among Children Hospitalized for Acute Asthma Exacerbations.
    Int Arch Allergy Immunol. 2026 Oct 10:1. doi: 10.1159.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

11. SOLOMON Z, Gomi R, Verzani Z, Wu A, et al
    Lower Nasal Sphingolipids in Pediatric Asthma and Cell-Type-Specific Effects of 17q21 Variants.
    J Allergy Clin Immunol. 2026 Oct 16:S0091-6749(26)00723.
    PubMed         Abstract available
    
    

    
    Respir Med

12. TREISTER-GOLTZMAN Y, Menashe I, Nemet D
    Association between obesity and asthma among Arab Israeli adolescents compared with Jewish Israeli peers.
    Respir Med. 2026 Oct 12:109214. doi: 10.1016/j.rmed.2026.109214.
    PubMed         Abstract available
    
    
13. KHAN JR, Jaffe A, Homaira N
    A Decade of Asthma Emergency Department Presentations in New South Wales: Temporal, Seasonal and Age-Specific Trends.
    Respir Med. 2026 Oct 12:109213. doi: 10.1016/j.rmed.2026.109213.
    PubMed         Abstract available
    
    
14. BOURDIN A, Canonica GW, Virchow JC, Jacob-Nara J, et al
    Real-world effectiveness of dupilumab in patients with severe asthma in Europe: Findings from the EU-ADVANTAGE study.
    Respir Med. 2026;263:109211.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum